DK173592B1 - Rekombinant viral ekspressionsvektor, som er i stand til i en transformant hvirveldyrcellekultur at udtrykke en DNA-sekvens - Google Patents

Rekombinant viral ekspressionsvektor, som er i stand til i en transformant hvirveldyrcellekultur at udtrykke en DNA-sekvens Download PDF

Info

Publication number
DK173592B1
DK173592B1 DK198203869A DK386982A DK173592B1 DK 173592 B1 DK173592 B1 DK 173592B1 DK 198203869 A DK198203869 A DK 198203869A DK 386982 A DK386982 A DK 386982A DK 173592 B1 DK173592 B1 DK 173592B1
Authority
DK
Denmark
Prior art keywords
hbsag
dna
vector
cell culture
viral
Prior art date
Application number
DK198203869A
Other languages
Danish (da)
English (en)
Other versions
DK386982A (da
Inventor
Daniel G Yansura
Arthur D Levinson
Chung-Cheng Liu
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26970555&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK173592(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK386982A publication Critical patent/DK386982A/da
Priority to DK200100192A priority Critical patent/DK200100192A/da
Application granted granted Critical
Publication of DK173592B1 publication Critical patent/DK173592B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
DK198203869A 1981-08-31 1982-08-30 Rekombinant viral ekspressionsvektor, som er i stand til i en transformant hvirveldyrcellekultur at udtrykke en DNA-sekvens DK173592B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200100192A DK200100192A (da) 1981-08-31 2001-02-06 Vaccine mod hepatitis B-virus hos mennesker

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US29823581A 1981-08-31 1981-08-31
US29823581 1981-08-31
US32698081A 1981-12-03 1981-12-03
US32698081 1981-12-03

Publications (2)

Publication Number Publication Date
DK386982A DK386982A (da) 1983-03-01
DK173592B1 true DK173592B1 (da) 2001-04-09

Family

ID=26970555

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198203869A DK173592B1 (da) 1981-08-31 1982-08-30 Rekombinant viral ekspressionsvektor, som er i stand til i en transformant hvirveldyrcellekultur at udtrykke en DNA-sekvens

Country Status (17)

Country Link
EP (2) EP0291586A3 (no)
JP (3) JPS5856685A (no)
AU (2) AU555575B2 (no)
BR (1) BR8205078A (no)
DE (1) DE3280310D1 (no)
DK (1) DK173592B1 (no)
ES (1) ES515260A0 (no)
GB (1) GB2105344B (no)
GR (1) GR76906B (no)
HK (1) HK29689A (no)
HU (1) HU196238B (no)
IE (1) IE53873B1 (no)
IL (1) IL66637A (no)
KE (1) KE3838A (no)
NO (1) NO165598C (no)
NZ (1) NZ201706A (no)
ZW (1) ZW18282A1 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196194A (en) * 1979-05-24 1993-03-23 The Regents Of The University Of California Vaccines containing Hepatitis B S-protein
US4769238A (en) 1981-08-04 1988-09-06 The Regents Of The University Of California Synthesis of human virus antigens by yeast
ZW18282A1 (en) 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
JPS5936698A (ja) * 1982-08-20 1984-02-28 Science & Tech Agency B型肝炎ウイルス遺伝子を組込んだ組換えdnaおよび形質転換動物細胞
CA1209501A (en) * 1982-09-16 1986-08-12 Nikos Panayotatos Expression vector
US4820642A (en) * 1983-04-04 1989-04-11 The Regents Of The University Of California Amplified expression vector
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
EP0140762A1 (fr) * 1983-10-03 1985-05-08 Transgene S.A. Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application à la préparation d'un vaccin
FR2552776B1 (fr) * 1983-10-03 1986-05-09 Transgene Sa Vecteurs d'expression d'une proteine antigenique de la rage dans les cellules eucaryotes et leur application a la preparation d'un vaccin
JPS6078999A (ja) * 1983-10-05 1985-05-04 Chemo Sero Therapeut Res Inst HBs抗原の精製方法
US5639639A (en) * 1983-11-02 1997-06-17 Genzyme Corporation Recombinant heterodimeric human fertility hormones, and methods, cells, vectors and DNA for the production thereof
US5118627A (en) * 1984-02-27 1992-06-02 Amgen Papova virus construction
FR2560890B1 (fr) * 1984-03-07 1987-10-16 Grp Genie Genetique Composition utile pour la fabrication de vaccins contenant des particules portant l'antigene de surface du virus de l'hepatite b et le recepteur de l'albumine serique humaine polymerisee, cellules animales capables de produire de telles particules et procede pour leur obtention
US4777240A (en) * 1984-03-08 1988-10-11 Scripps Clinic And Research Foundation SV40 expression vector containing HBxAg as an expression marker
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
US4663281A (en) * 1984-03-22 1987-05-05 Mass Institute Of Technology Enhanced production of proteinaceous materials in eucaryotic cells
FR2564106B1 (fr) * 1984-05-09 1988-04-22 Transgene Sa Vecteurs d'expression du facteur ix, cellules transformees par ces vecteurs et procede de preparation du facteur ix.
US5683688A (en) * 1984-05-31 1997-11-04 Genentech, Inc. Unglycosylated recombinant human lymphotoxin polypeptides and compositions
WO1986006405A1 (en) * 1985-05-02 1986-11-06 Takeda Chemical Industries, Ltd. Novel transformant and its use
EP0213628A3 (en) * 1985-09-03 1988-09-21 Yeda Research And Development Company, Ltd. Expression of superoxide dismutase in eukaryotic cells
SE8505027D0 (sv) * 1985-10-24 1985-10-24 Kabigen Ab A lytic virulent phage, a hostcell containing same and a process for protein production
KR950001993B1 (ko) * 1985-12-18 1995-03-08 마이크로제네시스,인코포레이티드 B형 간염 표면항원의 제조방법
AU582288B2 (en) * 1986-03-07 1989-03-16 Damon Biotech Inc. Vector and method for achieving high level expression in eukaryotic cells
US5004693A (en) * 1986-07-18 1991-04-02 E. I. Du Pont De Nemours And Company Pseudorabies virus recombinants and their use in the production of proteins
NZ219516A (en) * 1987-02-10 1991-02-26 Wellcome Found Fusion proteins of hbcag (hepatitis b virus core antigen)
US5024939A (en) * 1987-07-09 1991-06-18 Genentech, Inc. Transient expression system for producing recombinant protein
US5443964A (en) * 1987-08-10 1995-08-22 Duke University Poxvirus insertion/expression vector
US5578468A (en) * 1987-08-10 1996-11-26 Duke University Site-specific RNA cleavage
JPH01285196A (ja) * 1988-05-11 1989-11-16 Chisso Corp 発光蛋白エクオリンの製造法
US5709995A (en) 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
JP4085231B2 (ja) 2000-02-28 2008-05-14 株式会社ビークル タンパク質中空ナノ粒子とそれを用いた物質運搬体、ならびに細胞への物質導入方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636191A (en) * 1969-10-08 1972-01-18 Cancer Res Inst Vaccine against viral hepatitis and process
US4164565A (en) * 1975-03-14 1979-08-14 New York Blood Center, Inc. Vaccine for active immunization containing hepatitis B surface antigen and associated antigen
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
FR2444713A1 (fr) 1978-12-18 1980-07-18 Pasteur Institut Procede de production d'un adn comprenant le genome du virus de l'hepatite b et vecteur le comportant
DD147855A5 (de) * 1978-12-22 1981-04-22 Biogen Nv Verfahren zur erzeugung mindestens eines hbv-antigenwirkung aufweisenden polypeptids
IE52036B1 (en) 1979-05-24 1987-05-27 Univ California Non-passageable viruses
JPS5610119A (en) * 1979-07-05 1981-02-02 Alpha Therapeutic Corp Manufacture of b type hepatitis infection preventive vaccine
US4399216A (en) * 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811895B (en) * 1980-04-07 1982-04-28 Univ California Expression of hormone genomic clones
EP0038765B1 (fr) * 1980-04-22 1987-09-02 Institut Pasteur Vaccin contre l'hépatite virale B, procédé et cellules eucaryotes transformées pour la production de ce vaccin
FR2480780B1 (fr) * 1980-04-22 1985-12-06 Pasteur Institut Procede de transformation de cellules, notamment eucaryotes, par un adn circulaire tel que celui du virus de l'hepatite b et preparations contenant les produits d'expression desdits adn
EP0062574A3 (en) * 1981-03-31 1982-12-29 The Regents Of The University Of California Virus protein synthesis
JPS5813598A (ja) * 1981-06-22 1983-01-26 イーライ・リリー・アンド・カンパニー 組み替えdnaクロ−ニング・ベクタ−ならびにその真核細胞性および原核細胞性被形質転換体
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
ZW18282A1 (en) 1981-08-31 1983-03-23 Genentech Inc Preparation of polypeptides in vertebrate cell culture
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
FR2521165A1 (fr) * 1982-02-08 1983-08-12 Pasteur Institut Fragments d'adn codant pour un peptide immunogene susceptible d'introduire in vivo la synthese d'anticorps anti-poliovirus
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes

Also Published As

Publication number Publication date
ES8401134A1 (es) 1983-12-01
JPH06261748A (ja) 1994-09-20
HU196238B (en) 1988-10-28
IE822084L (en) 1983-02-28
JPH0937777A (ja) 1997-02-10
AU6167186A (en) 1987-01-08
AU589673B2 (en) 1989-10-19
BR8205078A (pt) 1983-08-09
NO165598B (no) 1990-11-26
EP0073656A3 (en) 1984-10-24
DK386982A (da) 1983-03-01
IL66637A (en) 1991-11-21
ZW18282A1 (en) 1983-03-23
IE53873B1 (en) 1989-03-29
AU555575B2 (en) 1986-10-02
KE3838A (en) 1988-12-02
EP0291586A2 (en) 1988-11-23
NO822926L (no) 1983-03-01
GR76906B (no) 1984-09-04
EP0073656B1 (en) 1991-03-06
AU8779882A (en) 1983-03-10
NZ201706A (en) 1986-05-09
DE3280310D1 (de) 1991-04-11
JP2726641B2 (ja) 1998-03-11
HK29689A (en) 1989-04-14
GB2105344B (en) 1985-10-09
EP0291586A3 (en) 1988-12-07
EP0073656A2 (en) 1983-03-09
JP2634371B2 (ja) 1997-07-23
IL66637A0 (en) 1982-12-31
JPS5856685A (ja) 1983-04-04
JPH0587518B2 (no) 1993-12-16
GB2105344A (en) 1983-03-23
NO165598C (no) 1991-03-06
ES515260A0 (es) 1983-12-01

Similar Documents

Publication Publication Date Title
DK173592B1 (da) Rekombinant viral ekspressionsvektor, som er i stand til i en transformant hvirveldyrcellekultur at udtrykke en DNA-sekvens
JP2511394B2 (ja) 酵母菌中でのb型肝炎表面抗原の製造
JP2610015B2 (ja) アデノウイルスプロモーターの制御下で所定のポリペプチドをコードしているヌクレオチド配列を含む組換えdna
US5314808A (en) Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of a B viral hepatitis, and preparations containing the expression products of said DNAs
EP0244924B1 (en) Production of vaccines against Hepatitis B virus
JPH0884588A (ja) ヘテロポリマー系蛋白質
NO304268B1 (no) FremgangsmÕte for fremstilling av et protein med aminosyresekvens som bestÕr av deler av aminosyre-sekvensen til hepatitt B-virus-stort (L) protein, vertscelle transformert med DNA som koder for proteinet, samt anvendelse av et protein eventuelt
EP0101617A2 (en) Recombinant DNA containing a hepatitis B virus gene, mammalian cells transformed with the cloned viral DNA, and production of hepatitis B virus proteins
DK166357B (da) Partikler med immunogene egenskaber svarende til hbs antigen samt vektorer og animalske celler til produktion af saadanne partikler
JPH08308575A (ja) 組換アデノウイルス
US4741901A (en) Preparation of polypeptides in vertebrate cell culture
CA1222707A (en) Preparation of hepatitis b virus vaccine
Stenlund et al. Secretion of the hepatitis B virus surface antigen from mouse cells using an extra‐chromosomal eucaryotic vector.
JPH0314840B2 (no)
Stratowa et al. Recombinant retroviral DNA yielding high expression of hepatitis B surface antigen.
ES2264183T3 (es) Metodo para obtener antigeno de superficie del virus de la hepatitis b (hep b), recombinante, con capacidad inmunogenica superior y su uso en una preparacion de vacuna.
EP0105141A2 (en) Recombinant DNA molecules, process for their production, their use for production of hepatitis B surface antigen (HBsAg) and pharmaceutical compositions containing this HBsAg
Denniston et al. Expression of hepatitis B virus surface and e antigen genes cloned in bovine papillomavirus vectors
JPS61500971A (ja) B型肝炎ウイルスの表面抗原と重合ヒト血清アルブミンレセプタ−とを有する粒子を含むワクチン製造に有用な組成物、前記の如き粒子を産生し得る動物細胞、並びにこれら細胞を得るための方法
AU4315689A (en) Defective hepadnaviruses and producer cell line for vaccines and treatment of liver diseases and disorders
NO885658L (no) Retrovirusekspresjonsvektorer og fremgangsmaater for fremstilling av hbv-antigener.
EP0257507A1 (en) Hepatitis vaccine
PT85108B (pt) Virus da varicela-zoster util como vacina viva recombinante
DK173671B1 (da) Fremgangsmåde til selektion af transficerede hvirveldyrceller
Marquardt Hepatitis B virus components produced by the human hepatoma cell line PLC/PRF/5: Do they indicate virus propagation?

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired